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A M ODEL FOR A NESTHETIC WASHOUT D URING R ECOVERY IN THE
P OST A NESTHESIA C ARE U NIT
Cameron Jacobson
Department of Bioengineering, University of Utah, Salt Lake City, UT

Abstract—Hypercapnia with hyperventilation during emergence from anesthesia has been shown to reduce emergence time,
yet little is known about how the subsequent recovery in the post
anesthesia care unit (PACU) is affected. A mathematical model
has been developed to investigate how inhaled anesthetic agents
wash out of patients during recovery in order to demonstrate
any difference that hypercapnia and hyperventilation during
emergence might have on recovery.

I. I NTRODUCTION
ENERAL anesthesia is composed of four phases: induction, maintenance, emergence, and recovery. During the
induction phase, patients are placed in an anesthetized state
and intubated in preparation for surgery. Maintenance is the
continual administration and monitoring of anesthesia during
surgery. At the end of surgery, anesthesia is discontinued and
the patient is ventilated until they emerge from anesthesia, i.e.
their anesthetic level is such that they regain consciousness
and breathe spontaneously. Lastly, they are extubated and
transported to the PACU for recovery.
The durations of the emergence and recovery phases are
influenced by several factors: demographics, surgery length,
anesthetic type, hemodynamics, and ventilation. First, demographics, especially body type, can affect how anesthetic is
stored in the tissues of the body, e.g. fatty tissues store large
amounts of anesthetic compared to other tissue types, hence,
washout of the anesthetic can differ from patient to patient.
Second, surgery length directly affects how long tissues are
exposed to anesthetic agent. Third, anesthetic solubility is a
measure of how easily anesthetic dissolves in blood and differs
from agent to agent. For example, desflurane has a blood/gas
solubility coefficient of 0.45, sevoflurane 0.65, and isoflurane
1.40[1], [2]. As a result desflurane washes out faster than
sevoflurane, and sevoflurane washes out faster than isoflurane.
Lastly, hemodynamics and ventilation affect the way in which
gases, including anesthetics, enter, exit, and move throughout
the body.
The cardiovascular and respiratory systems work in tandem
to provide the necessary gas exchange for cellular metabolic
activity throughout the body. The respiratory system exchanges
O2 and CO2 between the atmosphere and blood; the circulatory system delivers the O2 to the cells throughout the body
and transports CO2 , a byproduct of cellular respiration, from
the cells back to the lungs. When the concentration of CO2 in
the blood fluctuates, the cardiovascular and respiratory systems
are adjusted to compensate. For example, if the arterial partial
pressure of CO2 (PaCO2 ) rises—due to exercise or some kind
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of strenuous activity—breathing rate and cardiac output will
increase and vasodilation will occur, causing an increasing in
blood flow and gas exchange in the lungs in order to flush the
body of excess CO2 . When PaCO2 decreases, the opposite
occurs. In the operating room, this principle is frequently
taken advantage of in an effort to accelerate recovery from
anesthesia.
Induced hypercapnia, or elevated PaCO2 , can be used to
accelerate a patient’s recovery by washing anesthetic vapors
from the body in the same way that excess CO2 is removed[3],
[4]. Hypercapnia during emergence has two important consequences: it increases cerebral blood flow—helping to quickly
wash anesthetic from the brain; and it stimulates respiratory
drive[5], [6], [7]. Coupled with hyperventilation, a patient
is able to expel anesthetic vapors quickly and emerge from
anesthesia sooner with a stronger respiratory drive.
A device, developed in our lab, called the QED-100
(Anecare, Salt Lake City, UT), is used to accomplish this
task in many hospitals today[8]. The QED-100 incorporates
a rebreathing reservoir to induce hypercapnia and a charcoal
filter to capture expelled anesthetic gases. The QED-100 is
capable of reducing emergence time by approximately 55%[8],
[9], [10]. This result translates not only into a cost savings
from less time spent in the OR, but perhaps more importantly,
it produces a patient that can enter the PACU with less
anesthetic in their system and a stronger respiratory drive,
which in turn could lead to a faster, safer, and more satisfactory
recovery.
The incidence rate of complications in the OR and PACU
were estimated to be 1.3-5.1% and 23-24% respectively based
on a collection of over 42,000 patients[11], [12], [13]. PONV
and upper airway support were the most common events
encountered in the PACU, each accounting for roughly 1/3 of
all PACU complications (2/3 combined). One of the possible
reasons for the increased rate of complications in the PACU
may stem from the fact that as patients become more alert,
they become more aware of pain and often require additional
analgesic for pain management. Analgesics can react synergistically with residual inhaled anesthetic still present in the
patient’s body, similar to how they react during the induction
phase of anesthesia, which can result in adverse clinical events
(e.g. respiratory depression or even loss of consciousness). Of
course, there are several other factors contributing to the likelyhood of complications in the PACU: surgery type, surgery
length, ASA physical status, and anesthetic technique[11],
[13]. However, aside from these factors, it stands to reason
that a patient entering the PACU with less anesthetic in their
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system may have a greater chance of avoiding complications.
While it has been shown that hypercapnia with hyperventilation shortens emergence time by removing inhaled anesthetic
quickly, the actual levels of anesthetic that patients endure
during recovery are not well known. A study, already in
progress, has been designed to collect this data, which will
then be used to validate the model for anesthetic washout.
Lerou et al. described a mathematical model for the uptake and distribution of inhaled anesthetic in a closed-circuit
system[1]. A similar model has been developed to simulate
not only uptake and distribution of anesthetic agent, but also
washout after the breathing circuit has been removed and the
patient is breathing spontaneously. Such a model will provide
estimates of agent concentration throughout the body that
would be difficult to attain through direct measurement—the
most important one being cerebral concentration.
In Gopalikrishnan’s disseration, he used a similar model to
determine cerebral concentrations of anesthetic agent during
emergence in order to estimate wake up times[14]. He was
able to show that hypercapnia with hyperventilation during
emergence quickly reduced the cerebral concentration of anesthetic agent, resulting in a faster wake up time. Likewise, an
analogous method will be implemented in order to determine
the cerebral concentration of anesthetic agent during key points
of recovery. Such a model will provide information that could
aid in the developement of a hypercapnia-inducing device for
the PACU or simply decision support for clinical staff.
II. M ETHODS
The mathematical model is based on a similar model
described and clinically validated by Lerou, et al. [1], [15].
It consists of 13 compartments that each represent a particular
tissue type or blood pool in the body. Each compartment
is fashioned from a basic model where a solute of known
concentration flows into a compartment of known volume,
having also an outlet with known flow (Figure 1(a)). The
ordinary differential equation describing such a scenario is
given Figure 1(b) where VB is the volume of the compartment,
Ci is the concentration of the incoming solute with flow rate
Qi , and CB is the concentration in the compartment and
outgoing solute with flow Qo .
From this basic model, a network of compartments was
constructed to simulate the flow of solute through the various
tissue groups and blood pools of the body. The solute in this
model is the inhaled anesthetic desflurane. As described in
Figure 2, the agent is taken in through the lungs, then into
the arterial blood pool—blood pools in the model introduce
a time delay to simulate circulation time. The arterial blood
distributes the anesthetic agent to the various tissue groups,
which then empty into the venous blood pool before returning
to the lungs.
A data set collected from patients during surgery and
recovery from anesthesia will be used to validate the model.
This step is currently underway. Following IRB approval,
44 patients undergoing eye muscle surgery will be randomly
divided in to two groups: a treatment group, which will
be hypercapnic and hypervenilated during emergence; and a
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Fig. 1.
The basic model. (a) Diagram of the basic model showing a
compartment B, with known volume VB , and concentration of solute CB ,
also having incoming flow Qi with concentration Ci and out going flow
Qo with concentration CB . (b) Ordinary differential equation describing the
rate of change in concentration CB . (c) Simulink model that describes the
equation in (b).

control group. End tidal CO2 (EtCO2 ), end tidal and inspired
anesthetic agent concentration, and minute volume (MV) will
be recorded during surgery and recovery. This data will be
used to drive the model to simulate induction, maintenance,
and emergence phases of anesthesia. In this way, the model
will be preloaded with the correct amounts of agent so that
washout during recovery can be simulated accurately.
From the patient demographics, lean body weight (LBW )
will be estimated as
LBW = (1.1 × BW −

LBW = (1.07 × BW −

128 × BW 2
(male)
(100 × H)2
148 × BW 2
(female)
(100 × H)2

where BW is measured body weight and H is measured
height[16]. Subsequantly, several other physiological values
will be derived from LBW for the model: blood volume, tissue volumes, cardiac output, alveolar space, etc[1]. A summary
of the variables, symbols, and their relationships are given in
Table I.
Using the basic model as a template (Figure 1(b)), the
equation describing the rate of change in agent concentration
for the alveolar space is
(Des − CA )M V + (CV − Ca0 )QL
dCA
=
.
dt
VA
The first term in the numerator describes the net change in
concentration due to inhalation and exhalation of the gaseos
agent; the second term describes the change in terms of the
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TABLE I
S YMBOLS AND RELATIONSHIPS AMONG VARIABLES [1], [2]
Relationship \Value

Variable

Description

A
BW
H

age (y)
body weight (kg)
height (m)

Demographics
—
—
—
F ractional Concentrations
Ca
Ca0
Ca00

agent leaving arterial pool
agent in blood exposed to alveolar gas
agent entering arterial pool

CA

agent in alveolar gas

Cat

agent leaving adipose tissue

Cb

agent leaving brain tissue

Cct

agent leaving connective tissue

Ch

agent leaving heart tissue

Ck

agent leaving kidney tissue

Cl

agent leaving liver tissue

Cm

agent leaving muscle tissue

Cvpa0

agent leaving venous pool: adipose tissue

Cvpl

agent entering venous pool: lean tissue

Cvpl0

agent leaving venous pool: lean tissue

Cvpv

agent entering venous pool: viscera

Cvpv0

agent leaving venous pool: viscera

Cv

agent leaving central venous pool

Cv 0
Des

agent entering central venous pool
agent in inspired air

dCa
dt

Q

(C 00 −Ca )

= CO V a
bla
Ca0 = λb CA
Ca00 = Ca0 (1 − Qf s ) + Cv Qf s

(Des−CA )M V +(CV −C 0 )QL
dCA
a
dt =
VA
dCat
(Ca −Cat )Qat
=
dt
Vat λat
dCb
(Ca −Cb )Qb
dt =
Vb λb
dCct
(Ca −Cct )Qct
=
dt
Vct λct
(Ca −Ch )Qh
dCh
dt =
Vh λh
dCk
(Ca −Ck )Qk
dt =
V k λk
dCl
(Ca −Cl )Ql
dt =
Vl λl
(Ca −Cm )Qm
dCm
=
dt
V m λm
dC
(Cat −C
)Qat
vpa0
vpa0
=
dt
Vvpa
Cm Qm +Cct Qct
Cvpl =
Qm +Qct
)(Qm +Qct)
(Cvpl −C
dC
vpl0
vpl0
=
dt
Vvpl
Cb Qb +Ch Qh+Ck Qk +Cl Ql
Cvpv =
Qb +Qh +Qk +Ql
(Cvpv −C
)(Qb +Qh +Qk +Ql )
dCvpv
vpv 0
=
dt
Vvpv
(C 0 −Cv )QCO
dCv
v
=
dt
Vvpc
C
0 (Qb +Qh +Qk +Ql )+Cvpl0 (Qm +Qct )+Cvpa0 Qat
Cv0 = vpv
QCO

recorded concentration in Aim 1
F lows (L/min)

MV
Qat
Qb
QCO
Qct
Qf s
Qh
Qk
Ql
Qm

minute volume
flow through adipose tissue
flow through brain tissue
cardiac output
flow through connective tissue
flow through pulmonary shunt
flow through heart tissue
flow through kidney tissue
flow through liver tissue
flow through muscle tissue

F RC
F RC
VA
Vat
Vb
Vbl
Vbla
Vblv
Vct
Vd
Vh
Vk
VL
Vl
Vm
Vvpa
Vvpc
Vvpl
Vvpv
Vt

function residual volume
function residual volume
alveolar space
adipose tissue blood
brain tissue blood
total blood
arterial blood
venous blood
connective tissue blood
dead space
heart tissue blood
kidney tissue blood
lung tissue blood
liver tissue blood
muscle tissue blood
venous pool: adipose tissue
central venous pool
venous pool: lean tissue
venous pool: viscera
tidal volume

recorded MV in Aim 1
Qat = 0.05 × QCO
Qb = 0.16 × QCO
QCO = 0.2 × LBW
Qct = 0.06 × QCO
0.05
Qh = 0.05 × QCO
Qk = 0.25 × QCO
Ql = 0.3 × QCO
Qm = 0.13 × QCO
V olumes (L)
F RC = 0.65(2.34H + 0.009A − 1.090) [male]
F RC = 0.65(2.24H + 0.001A − 1) [female]
VA = F RC + 0.8Vt + VL λb λL
Vat = 0.15 × LBW
Vb = 0.021 × LBW
Vbl = 0.07 × LBW
Vbla = 0.2 × Vbl
Vblv = 0.8 × Vbl
Vct = 0.26 × LBW
Vd = 0.002 × LBW
Vh = 0.004 × LBW
Vk = 0.004 × LBW
VL = 0.008 × LBW
Vl = 0.057 × LBW
Vm = 0.426 × LBW
Vvpa = 0.111 × Vblv
Vvpc = 0.126 × Vblv
Vvpl = 0.364 × Vblv
Vvpv = 0.399 × Vblv
mean of recorded TV in Aim 1

P artition Coef f icients f or Desf lurane
λat
λB
λb
λct
λh
λk
λL
λl
λm

tissue-blood
blood-gas
tissue-blood
tissue-blood
tissue-blood
tissue-blood
tissue-blood
tissue-blood
tissue-blood

in adipose tissue
in
in
in
in
in
in
in

brain tissue
connective tissue
heart tissue
kidney tissue
lung tissue
liver tissue
muscle tissue

29.0
0.45
1.22
1.40
1.22
0.89
1.30
1.49
1.73
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The next major tissue groups, muscle and connective tissue,
drain into a blood pool called the venous pool lean tissue. The
concentration entering this pool is

Inhaled air with concentration
Des and flow MV
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Fig. 2. The 13 compartment model to simulate the uptake, distribution, and
washout of inhaled anesthetic agent. See Table I for variable descriptions and
relationships.

liquid agent in the blood stream using the appropriate bloodgas partition coefficient for desflurane and noting that Ca0 =
λB CA . As blood leaves the lungs, it mixes with the blood from
the pulmonary shunt. This mixture enters the artial blood pool
with concentration
Ca00 = Ca0 (1 − Qf s ) + Cv Qf s .
For the arterial blood pool, the change in concentration is
dCa
QCO (Ca00 − Ca )
=
,
dt
Vbla
which is then distributed to the major tissue compartments.
The tissue compartments can be described similarly as
dCt
Qt (Ca − Ct )
=
dt
Vt λt
where the subscript t denotes one of the seven tissue types.
The venous blood draining the brain, heart, kidney, and liver
(i.e. viscera) combines and enters a blood pool, called the
venous pool viscera, with concentration
Cvpv =

Cb Qb + Ch Qh + Ck Qk + Cl Ql
.
Qb + Qh + Qk + Ql

The blood exiting the venous pool viscera then has concentration
dCvpv
(Cvpv − Cvpv0 )(Qb + Qh + Qk + Ql )
=
.
dt
Vvpv

Cm Qm + Cct Qct
Qm + Qct

and leaving
dCvpl0
(Cvpl − Cvpl0 )(Qm + Qct)
=
.
dt
Vvpl
The last tissue group, adipose tissue, drains into the venous
pool adipose with concentration Cat . The concentration leaving the pool is
(Ca − Cat )Qat
dCat
=
.
dt
Vat λat
Finally, the venous blood from the three venous pools
is collected into the central venous pool. Their combined
concentration is
Cvpv0 (Qb + Qh + Qk + Ql )
Cv 0 =
(1)
QCO
Cvpl0 (Qm + Qct ) Cvpa0 Qat
+
+
.
(2)
QCO
QCO
The concentration leaving the central venous pool and returning to the lungs is
(Cv0 − Cv )QCO
dCv
=
,
dt
Vvpc
concluding the family of equations that describe the model.
It has also been shown that PaCO2 influences cerebral blood
flow, and so the following exponential relationship will be used
to alter cerebral blood flow as a function of PaCO2 .
CBF = 4.29e0.0589EtCO2 ,
where CBF is cerebral blood flow in ml · min−1 · 100g−1 and
PaCO2 has been estimated using the easily measured EtCO2
(mmHg)[17].
The model will be evaluated in Simulink (Mathworks,
Natick, MA). Figure 1(c) shows the equivalent Simulink
model for the basic model described in the Figures 1(a) and
1(b). Besides its intuitive graphical interface for constructing
models, another useful feature in Simulink is its modular
approach to building complex models. The basic model in
Figure 1(c) can be encapsulated in its own block or module,
and then a series of these modules can be interconnected to
form the network that describes the model in Figure 2. The
equivalent Simulink model is shown in Figure 3.
III. R ESULTS
The plot in Figure 4 shows a simulation of anesthetic concentrations during surgery, emergence, transport, and recovery
of a typical patient. The blue line shows the concentration
of inspired agent as recorded by the anesthesia machine.
The red and cyan show the simulated arterial and cerebral
concentrations. The purple and green lines show the measured
and simulated end tidal anesthetic concentration respectively .
At the beginning of surgery, the clinician usually gives a
high dose of agent concentration in order to quickly reach
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Fig. 4. Simulation of anesthetic concentration for a typical patient. Note the close approximation of the simulated end tidal anesthetic agent to the measured
one (purple and green lines respectively). The blue line shows the inspired concentration. The red and cyan lines show the arterial concentration and cerebral
concentration respectively. The cerebral concentration is modeled as a function of PaCO2 . The bottom graph shows an expanded view of the washout period
during recovery.

the maintenance value of 6% end tidal agent concentration as
quickly as possible. Often this results in a brief overshoot, as
seen as the spike in concentration at the beginning of the case.
It can also be seen that the simulated end tidal concentration
nearly approximates the measured end tidal concentration.
This is most evident during the surgery and emergence periods.
During the transport period, when the patient is being disconnected from the anesthesia equipment and moved to the PACU,
the approximation differs more, but then seems to merge again
during recovery.
The bottom smaller graph shows an expanded view of the
recovery period. In this view it can be seen that the simulated
curve is slightly higher than the measured curve for nearly the
entire period.
When a paired t-test was performed on the end tidal data
for the surgery and emergence periods for 18 patients enrolled
in the study thus far, the difference between the simulated and
measured data was not significant, but during the transport
and recovery periods the difference was significant—despite
the apparent small difference shown in the expanded view.
IV. D ISCUSSION
During the surgery and emergence periods, the patient data
(i.e. EtCO2 , end tidal and inspired agent concentration, and
MV) is recorded at a sample frequency of 30 sec. During
transport period, no data is recorded because no monitors
can be connected while the patient is moved from the OR

to the PACU. Once the patient enters the PACU and is
situated the sample frequency is 100 Hz. However, for this
first set of simulations, data points taken every 5 min during
recovery were used. This was because at every 5 min interval
a calibration test was performed using a gas analyzer and
spirometer to calibrate the second monitor—a device used
to measure minute volume using only inductance through
elastic bands placed around the chest and abdomen (this is
so that patients were not required to wear an airtight mask
during recovery). The data available via the gas analyzer and
spirometer during the calibration periods was readily available
for use in the simulation. The higher resolution data, after
some work, can be made available for use in the simulation.
And after performing the t-test, it is apparent that the higher
resolution data should be used to see if it improves the model.
The two main driving forces behind washout are ventilation
and cardiac output. As was mentioned, during transport no data
is recorded; and as illustrated in Figure 4 by the measured
end tidal signal, data points in the minute volume signal
were linearly interpolated as an initial attempt to compensate
for the lack of data. A better interpolation method could
probably be devised, although it is not really known how
minute volume changes during transport. Cardiac output could
also be modified to improve the model.
In the original 1991 Lerou model, cardiac output was approximated as constant, estimated as a fraction of body weight,
which was also used in this model for simplicity sake[1].
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Fig. 3. Simulink model describing the uptake, distribution, and washout of
inhaled anesthetic.

However, since then studies have shown how cardiac output
can be influenced by PaCO2 . In Gopalakrishnan’s dissertation,
he derived a relationship between cardiac output and PaCO2
based on measured data[14]. Implementing this relationship
might also improve washout.
V. C ONCLUSIONS
While the model overall appears to simulate anesthetic concentrations well, especially during the surgery and emergence
periods, the discrepancies seen in the transport and recovery
periods are different enough to be significant and need to be
addressed before this model can be used to effectively explore
anesthetic washout during recovery.
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